Treatment of severe and moderate hypertension with minoxidil: experience in twenty-eight patients. 1976

G Dunea, and B Mamdani, and S D Mahurkar

1. Twenty patients with severe or moderate hypertension were treated with minoxidil for 284 patient-months. 2. The blood pressure was controlled in all patients, including those refractory to maximal doses of conventional anti-hypertensive agents. 3. In patients with moderate hypertension control with minoxidil was achieved earlier and more easily than with hydrallazine. 4. Three patients developed secondary resistance and required addition of guanethidine or increased doses of diuretics. 5. Fluid retention and hypertrichosis were the main side effects with minoxidil.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D006983 Hypertrichosis Excessive hair growth at inappropriate locations, such as on the extremities, the head, and the back. It is caused by genetic or acquired factors, and is an androgen-independent process. This concept does not include HIRSUTISM which is an androgen-dependent excess hair growth in WOMEN and CHILDREN. Hypertrichoses
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008914 Minoxidil A potent direct-acting peripheral vasodilator (VASODILATOR AGENTS) that reduces peripheral resistance and produces a fall in BLOOD PRESSURE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p371) Loniten,Regaine,Rogaine,U 10858
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004487 Edema Abnormal fluid accumulation in TISSUES or body cavities. Most cases of edema are present under the SKIN in SUBCUTANEOUS TISSUE. Dropsy,Hydrops,Anasarca
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006830 Hydralazine A direct-acting vasodilator that is used as an antihypertensive agent. Hydrallazin,Apresoline,Apressin,Apressoline,Hydralazine Hydrochloride,Hydralazine mono-Hydrochloride,Hydrazinophthalazine,Nepresol,Hydralazine mono Hydrochloride,Hydrochloride, Hydralazine,mono-Hydrochloride, Hydralazine

Related Publications

G Dunea, and B Mamdani, and S D Mahurkar
January 1979, The Netherlands journal of medicine,
G Dunea, and B Mamdani, and S D Mahurkar
February 1981, Revista medica de Chile,
G Dunea, and B Mamdani, and S D Mahurkar
October 1975, Israel journal of medical sciences,
G Dunea, and B Mamdani, and S D Mahurkar
January 1982, Scandinavian journal of urology and nephrology,
G Dunea, and B Mamdani, and S D Mahurkar
January 1975, Current therapeutic research, clinical and experimental,
G Dunea, and B Mamdani, and S D Mahurkar
January 1986, Indian heart journal,
G Dunea, and B Mamdani, and S D Mahurkar
November 1977, Canadian Medical Association journal,
G Dunea, and B Mamdani, and S D Mahurkar
October 1980, The New England journal of medicine,
G Dunea, and B Mamdani, and S D Mahurkar
April 1979, Journal of clinical pharmacology,
G Dunea, and B Mamdani, and S D Mahurkar
July 1983, American journal of kidney diseases : the official journal of the National Kidney Foundation,
Copied contents to your clipboard!